BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gerlach K, Weigmann B. The dichotomous function of interleukin-9 in cancer diseases. J Mol Med (Berl) 2019;97:1377-83. [PMID: 31396657 DOI: 10.1007/s00109-019-01826-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bednarz-Misa I, Fortuna P, Diakowska D, Jamrozik N, Krzystek-Korpacka M. Distinct Local and Systemic Molecular Signatures in the Esophageal and Gastric Cancers: Possible Therapy Targets and Biomarkers for Gastric Cancer. Int J Mol Sci 2020;21:E4509. [PMID: 32630408 DOI: 10.3390/ijms21124509] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
2 Fang H, Li HF, Yan JY, Yang M, Zhang JP. Dexmedetomidine-up-regulated microRNA-381 exerts anti-inflammatory effects in rats with cerebral ischaemic injury via the transcriptional factor IRF4. J Cell Mol Med 2021;25:2098-109. [PMID: 33314611 DOI: 10.1111/jcmm.16153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Pasvenskaite A, Liutkeviciene R, Gedvilaite G, Vilkeviciute A, Liutkevicius V, Uloza V. The Role of IL-9 Polymorphisms and Serum IL-9 Levels in Carcinogenesis and Survival Rate for Laryngeal Squamous Cell Carcinoma. Cells 2021;10:601. [PMID: 33803218 DOI: 10.3390/cells10030601] [Reference Citation Analysis]
4 Cui G. TH9, TH17, and TH22 Cell Subsets and Their Main Cytokine Products in the Pathogenesis of Colorectal Cancer. Front Oncol 2019;9:1002. [PMID: 31637216 DOI: 10.3389/fonc.2019.01002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
5 Halama N. Bowel inflammation in cancer patients: the microbiome, antibiotics and interleukin-9. Br J Cancer 2020;123:1469-70. [PMID: 32843683 DOI: 10.1038/s41416-020-01030-0] [Reference Citation Analysis]